Inventor
BRADNER JAMES E
US37 patents
⚠️ This page may combine multiple inventors who share the name “BRADNER JAMES E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
18 patentsUS9714946B2Jul 25, 2017
Bromodomain binding reagents and uses thereof
DANA FARBER CANCER INST INC41 citations94
US10308653B2Jun 4, 2019
Diazepane derivatives and uses thereof
DANA FARBER CANCER INST INC8 citations84
US10150756B2Dec 11, 2018
Diaminopyrimidine benzenesulfone derivatives and uses thereof
DANA FARBER CANCER INST INC9 citations84
US9975896B2May 22, 2018
Inhibitors of transcription factors and uses thereof
DANA FARBER CANCER INST INC17 citations83
US9695172B2Jul 4, 2017
Diazepane derivatives and uses thereof
DANA FARBER CANCER INST INC13 citations83
US11306105B2Apr 19, 2022
Cyano thienotriazolodiazepines and uses thereof
DANA FARBER CANCER INST INC3 citations73
US10881668B2Jan 5, 2021
Acetamide thienotriazolodiazepines and uses thereof
DANA FARBER CANCER INST INC4 citations73
US9951074B2Apr 24, 2018
Dihydropteridinone derivatives and uses thereof
DANA FARBER CANCER INST INC6 citations73
US10793571B2Oct 6, 2020
Uses of diazepane derivatives
DANA FARBER CANCER INST INC2 citations72
US11406645B2Aug 9, 2022
Acetamide thienotriazolodiazepines and uses thereof
DANA FARBER CANCER INST INC0 citations62
US11236082B2Feb 1, 2022
EZH2 inhibitors and uses thereof
DANA FARBER CANCER INST INC0 citations62
US10730860B2Aug 4, 2020
Diaminopyrimidine benzenesulfone derivatives and uses thereof
DANA FARBER CANCER INST INC1 citations62
US10913752B2Feb 9, 2021
Bivalent bromodomain inhibitors and uses thereof
DANA FARBER CANCER INST INC1 citations61
US11446309B2Sep 20, 2022
Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
DANA FARBER CANCER INST INC0 citations59
US11666580B2Jun 6, 2023
Mechanism of resistance to bet bromodomain inhibitors
DANA FARBER CANCER INST INC0 citations53
US9458165B2Oct 4, 2016
DOT1L inhibitors
DANA FARBER CANCER INST INC0 citations49
US10633371B2Apr 28, 2020
EZH2 inhibitors and uses thereof
DANA FARBER CANCER INST INC0 citations38
US9535067B2Jan 3, 2017
DOT1L probes
DANA FARBER CANCER INST INC0 citations38
HARVARD COLLEGE
5 patentsUS9572854B2Feb 21, 2017
Treatment of protein degradation disorders
HARVARD COLLEGE6 citations82
US9540317B2Jan 10, 2017
Class- and isoform-specific HDAC inhibitors and uses thereof
HARVARD COLLEGE2 citations73
US10172905B1Jan 8, 2019
Treatment of protein degradation disorders
HARVARD COLLEGE3 citations71
US9434686B2Sep 6, 2016
Deacetylase inhibitors and uses thereof
HARVARD COLLEGE2 citations63
US10059657B2Aug 28, 2018
Class-and isoform-specific HDAC inhibitors and uses thereof
HARVARD COLLEGE0 citations52
VAN DUZER JOHN H
3 patentsUS8394810B2Mar 12, 2013
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
VAN DUZER JOHN H32 citations94
US8148526B1Apr 3, 2012
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
VAN DUZER JOHN H38 citations94
US8609678B2Dec 17, 2013
Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof
VAN DUZER JOHN H30 citations91
UNIV COLORADO STATE RES FOUND
3 patentsUS9186402B2Nov 17, 2015
Method for preparing largazole analogs and uses thereof
UNIV COLORADO STATE RES FOUND5 citations81
US10538534B2Jan 21, 2020
Synthesis and utility of new capgroup largazole analogs
UNIV COLORADO STATE RES FOUND1 citations58
US10676504B2Jun 9, 2020
Method for preparing largazole analogs and uses thereof
UNIV COLORADO STATE RES FOUND1 citations53